What is NDC 70771-1843?

70771-1843 is the product NDC for oxcarbazepine, Oxcarbazepine 300 mg/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.

Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for oxcarbazepine?

118 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

oxcarbazepine NDC 70771-1843 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)70771-1843Labeler and product segments. Claims need a package NDC.

Product NDC at billing width70771-1843Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
70771-1843-0	7077118430070771184300	1000 TABLET in 1 BOTTLE (70771-1843-0)Marketed from Jul 10, 2025
70771-1843-1	7077118430170771184301	100 TABLET in 1 BOTTLE (70771-1843-1)Marketed from Jul 10, 2025
70771-1843-4	7077118430470771184304	10 BLISTER PACK in 1 CARTON (70771-1843-4) / 10 TABLET in 1 BLISTER PACKMarketed from Jul 10, 2025
70771-1843-5	7077118430570771184305	500 TABLET in 1 BOTTLE (70771-1843-5)Marketed from Jul 10, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): oxcarbazepine
Generic name (nonproprietary): oxcarbazepine
Active ingredients: Oxcarbazepine — 300 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Zydus Lifesciences LimitedNDC labeler code 70771
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 211747
Marketing start: Jul 10, 2025
Listing expires: Dec 31, 2027
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 70771-1843_a783b6fe-6bb8-4684-a7a5-107288a969abSPL ID a783b6fe-6bb8-4684-a7a5-107288a969abSPL set ID e23d8a74-b47b-462a-b09c-90bdd58a032eRxCUI 312136, 312137, 312138UNII VZI5B1W380UPC 0370771184415, 0370771184217, 0370771184316
Pharmacologic class: Anti-epileptic Agent

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470771184300 followed by a unit qualifier and the quantity

Package 70771-1843-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 13, 2026.

Indications (excerpt from the label)

Oxcarbazepine is indicated for: Adults: -Monotherapy or adjunctive therapy in the treatment of partial-onset seizures Pediatrics: -Monotherapy in the treatment of partial-onset seizures in children 4 to 16 years -Adjunctive therapy in the treatment of partial-onset seizures in children 2 to 16 years ( 1 ) Oxcarbazepine tablets are indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70771-1843

What is NDC 70771-1843?: 70771-1843 is the product NDC for oxcarbazepine, Oxcarbazepine 300 mg/1 tablet, listed with the FDA by Zydus Lifesciences Limited. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: oxcarbazepine.
What is the active ingredient?: Oxcarbazepine.
Who is the labeler?: Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for oxcarbazepine?: 118 other product NDCs are listed under this name. See all oxcarbazepine NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other oxcarbazepine NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Zameer Pharmaceuticals LLC	90096-171	90096-0171-01
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Zameer Pharmaceuticals LLC	90096-172	90096-0172-01
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	Zameer Pharmaceuticals LLC	90096-173	90096-0173-01
Oxcarbazepine	Oxcarbazepine 300 mg/5mL	SuspensionOral	Novadoz Pharmaceuticals LLC	72205-354	72205-0354-85
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4664	70518-4664-0070518-4664-01
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-4663	70518-4663-0070518-4663-01
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-2084	67046-2084-03
Oxcarbazepine	Oxcarbazepine 300 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0868	67046-0868-03
Oxcarbazepine	Oxcarbazepine 600 mg/1	Tablet, Film coatedOral	Coupler LLC	67046-0179	67046-0179-03
Oxcarbazepine	Oxcarbazepine 150 mg/1	Tablet, Film coatedOral	Major Pharmaceuticals	0904-7593	00904-7593-61

All 119 oxcarbazepine NDCs

Other NDCs under ANDA 211747

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 211747
Product	Strength	Form · route	Labeler	Product NDC
oxcarbazepine	Oxcarbazepine 150 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-691
oxcarbazepine	Oxcarbazepine 300 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-692
oxcarbazepine	Oxcarbazepine 600 mg/1	TabletOral	Zydus Pharmaceuticals (USA) Inc.	68382-693
oxcarbazepine	Oxcarbazepine 150 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1842
oxcarbazepine	Oxcarbazepine 600 mg/1	TabletOral	Zydus Lifesciences Limited	70771-1844